UNSPSC 85494004: Supplement pericardium with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement pericardium with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02UN47Z

UNSPSC 85494004 Supplement pericardium with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code with no relevant recent state and local procurement activity. The six recent opportunities tagged to this code—including independent medical evaluation services for pension disability determinations, surgical benefit carve-outs for municipal employees, occupational medical surveillance for ferry workers, emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing—represent administrative healthcare contracting, workforce health and safety compliance, benefits administration, and staffing services that fall outside the procedural medical code's narrow scope. The code describes a specific surgical intervention on cardiac tissue and does not align with the administrative, occupational health, benefits management, or temporary staffing work state and local governments are actually buying under this classification.

State and local procurement activity under this code shows evident miscoding rather than genuine demand for pericardial tissue augmentation. Issuing bodies span diverse jurisdictions—municipal retirement offices (Phoenix), county health systems (Santa Clara), state transportation agencies (Washington), county juvenile justice (Harris County), and county human resources (Collier County)—but their actual needs involve benefits design, medical record administration, occupational compliance, and staffing coordination. No solicitation names surgical pericardial procedures as a deliverable. Until the state and local procurement taxonomy corrects this classification or produces opportunities genuinely aligned with pericardial tissue augmentation, the code carries no actionable business development signal.